The 12 Hallmarks of Aging in Dogs, Explained
Read full insightNicotinamide Riboside for Cats
By La Petite Labs Editorial 15 min read
References
Numbered references identify the sources used for specific claims. Read the study design, species and evidence boundaries alongside each finding.
-
Ratajczak J, Joffraud M, Trammell SA, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Study design/context: Mechanistic studySpecies/context: mouse, mammalian cellsEvidence boundary: Experimental pathway work; not canine or feline absorption, dosing, or clinical efficacy.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Study design/context: Pharmacokinetic studySpecies/context: human, mouseEvidence boundary: Human and mouse NAD-related biomarkers; not clinical benefit or a dose for pets.↩ 1 · ↩ 2
-
Marinescu AG, Chen J, Holmes HE, et al. Safety Assessment of High-Purity, Synthetic Nicotinamide Riboside (NR-E) in a 90-Day Repeated Dose Oral Toxicity Study, With a 28-Day Recovery Arm. Study design/context: 90-day oral toxicology study with recovery armSpecies/context: ratEvidence boundary: Sprague-Dawley rats received NR-E, a synthetic NR chloride preparation, for 90 days with a recovery arm. Not a feline safety trial or serving instruction.↩ 1 · ↩ 2
-
Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Study design/context: Randomized placebo-controlled crossover trialSpecies/context: humanEvidence boundary: Twelve older men in a 21-day crossover trial. Muscle NAD-related metabolites changed; muscle NAD+ and measured mitochondrial bioenergetics did not improve significantly. Not feline outcome evidence.↩ 1 · ↩ 2
-
Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Study design/context: Randomized double-blind placebo-controlled trialSpecies/context: humanEvidence boundary: Eight-week study in otherwise healthy overweight adults; adverse-event incidence and severity were similar across groups. ChromaDex-funded. Not feline dosing, efficacy or long-term feline safety.↩ 1 · ↩ 2
-
Li Q, Homilius M, Achilles E, et al. Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy. Study design/context: Observational metabolomics comparisonSpecies/context: catEvidence boundary: Observational serum-metabolite comparison; nicotinamide was lower in preclinical B1/B2 groups. No NAD-precursor supplementation or heart-tissue NAD measurement.↩
-
Ikeda M, Tsuji H, Nakamura S, Ichiyama A, Nishizuka Y, Hayaishi O. Studies on the biosynthesis of nicotinamide adenine dinucleotide. II. A role of picolinic carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals. Study design/context: Comparative biochemical enzyme experimentsSpecies/context: cat, ratEvidence boundary: Feline tissue enzyme activity and niacin nutrition; not NR dosing or clinical supplement efficacy.↩
-
U.S. Food and Drug Administration. “Complete and Balanced” Pet Food. Study design/context: Official guidanceSpecies/context: dogs, catsEvidence boundary: Nutritional adequacy labeling; does not establish whether an NAD+ supplement benefits cats.↩
-
G C Mills. Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. Study design/context: Biochemical mechanism experimentEvidence boundary: Biochemical erythrocyte experiment; no feline oral product effect inferred.↩
-
Cristina Cerqua, Alberto Casarin, Fabien Pierrel, Luis Vazquez Fonseca, Giampiero Viola, Leonardo Salviati, Eva Trevisson. Vitamin K2 cannot substitute Coenzyme Q10 as electron carrier in the mitochondrial respiratory chain of mammalian cells. Study design/context: Cell experimentsSpecies/context: human cells, yeastEvidence boundary: Human-cell/yeast experiments; cellular electron transport, not feline oral supplement benefit.↩
-
Ray M, Carney HC, Boynton B, Quimby J, Robertson S, St Denis K, Tuzio H, Wright B. 2021 AAFP Feline Senior Care Guidelines. Study design/context: Clinical practice guidanceSpecies/context: catEvidence boundary: Clinical assessment and practical care; not an NAD supplement trial.↩
-
EFSA NDA Panel, Turck D, et al. Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC. Study design/context: Scientific assessment for human food-supplement useSpecies/context: human, mouse, rat, dogEvidence boundary: Official assessment of a specified NR chloride material. Oral metabolism inference and ingredient-stability findings do not establish feline absorption, a cat dose or the storage time of a different finished formula mixed into food.↩ 1 · ↩ 2
Keep exploring
What would you like to understand next?
Search practical guides about healthy aging, cellular energy, ingredients, and daily support for cats.

